CoreCap Advisors’s Genmab GMAB Stock Holding History

CoreCap Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$143	Hold	4	–	–	﹤0.01%	3010
2026 Q2	$110	Buy	+4	New	+$106	﹤0.01%	3067

Other funds holding GMAB

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

CoreCap Advisors's GMAB Position: Q3 2026 in Review

CoreCap Advisors held its Genmab (GMAB) position steady in Q3 2026 at 4 shares worth $143. The position accounts for ﹤0.01% of the portfolio, ranked #3010.

CoreCap Advisors first reported a position in GMAB in Q2 2026 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

CoreCap Advisors held 4 shares of Genmab worth $143 as of Q3 2026.
CoreCap Advisors left its Genmab share count unchanged in Q3 2026.
Genmab made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #3010 holding.
CoreCap Advisors first reported a position in Genmab in Q2 2026 and has held it in 2 quarters since.
13 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.